TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
-0.34%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.63B
AUM Growth
+$2.63B
(-0.8%)
Cap. Flow
+$34.7M
Cap. Flow
% of AUM
1.32%
Top 10 Holdings %
Top 10 Hldgs %
39.68%
Holding
190
New
18
Increased
27
Reduced
27
Closed
13
Top Buys
| 1 |
Elevance Health
ELV
|
$45.7M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$22.8M |
| 3 |
Sarepta Therapeutics
SRPT
|
$19.9M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$18.2M |
| 5 |
Exelixis
EXEL
|
$14.1M |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$47.2M |
| 2 |
Stryker
SYK
|
$26.4M |
| 3 |
Zimmer Biomet
ZBH
|
$24.7M |
| 4 |
Lantheus
LNTH
|
$21.7M |
| 5 |
Humana
HUM
|
$19.9M |
Sector Composition
| 1 | Healthcare | 96.54% |
| 2 | Real Estate | 2.01% |
| 3 | Industrials | 0.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Amgen
AMGN
$155B
| $134M | 5.12% | 555,939 +47,263 | +9% | +$11.4M |
|
2
Gilead Sciences
GILD
$140B
| $129M | 4.93% | 1,559,884 +49,444 | +3% | +$4.1M |
|
|
3
Regeneron Pharmaceuticals
REGN
$61.5B
| $118M | 4.48% | 143,053 +22,191 | +18% | +$18.2M |
|
4
Johnson & Johnson
JNJ
$427B
| $112M | 4.26% | 721,779 +82,100 | +13% | +$12.7M |
|
5
UnitedHealth
UNH
$281B
| $111M | 4.21% | 234,173 -36,373 | -13% | -$17.2M |
|
6
Vertex Pharmaceuticals
VRTX
$100B
| $104M | 3.96% | 330,343 | – | – |
|
7
Eli Lilly
LLY
$657B
| $99.2M | 3.78% | 288,917 | – | – |
|
8
AbbVie
ABBV
$372B
| $81.5M | 3.1% | 511,599 +33,257 | +7% | +$5.3M |
|
9
Illumina
ILMN
$15.8B
| $80.9M | 3.08% | 348,079 +28,121 | +9% | +$6.54M |
|
10
Pfizer
PFE
$141B
| $72.4M | 2.76% | 1,775,076 +317,906 | +22% | +$13M |
|
11
AstraZeneca
AZN
$248B
| $68.9M | 2.62% | 992,664 -29,591 | -3% | -$2.05M |
|
12
Biogen
BIIB
$19.4B
| $67M | 2.55% | 240,926 +45,496 | +23% | +$12.6M |
|
13
Abbott
ABT
$231B
| $63.2M | 2.41% | 623,855 -69,196 | -10% | -$7.01M |
|
14
Merck
MRK
$210B
| $58.7M | 2.24% | 552,122 | – | – |
|
15
Thermo Fisher Scientific
TMO
$186B
| $54M | 2.06% | 93,705 | – | – |
|
|
16
Elevance Health
ELV
$71.8B
| $52.5M | 2% | 114,070 +99,426 | +679% | +$45.7M |
|
17
Moderna
MRNA
$9.37B
| $49.5M | 1.88% | 322,217 +57,290 | +22% | +$8.8M |
|
18
Cigna
CI
$80.3B
| $46.7M | 1.78% | 182,631 | – | – |
|
19
Bristol-Myers Squibb
BMY
$96B
| $46M | 1.75% | 663,796 -23,733 | -3% | -$1.64M |
|
|
SGEN
20
DELISTED
Seagen Inc. Common Stock
SGEN
| $45.5M | 1.73% | 224,663 +112,449 | +100% | +$22.8M |
|
|
21
Sarepta Therapeutics
SRPT
$1.78B
| $39.4M | 1.5% | 285,653 +144,694 | +103% | +$19.9M |
|
22
argenx
ARGX
$43.6B
| $32.9M | 1.25% | 88,310 +4,289 | +5% | +$1.6M |
|
23
Idexx Laboratories
IDXX
$51.8B
| $29.3M | 1.12% | 58,595 -9,470 | -14% | -$4.74M |
|
24
BioMarin Pharmaceuticals
BMRN
$11.2B
| $29.2M | 1.11% | 300,089 +69,299 | +30% | +$6.74M |
|
25
Intuitive Surgical
ISRG
$170B
| $28.8M | 1.1% | 112,680 | – | – |
|